Lucile Broyer

517 total citations
9 papers, 219 citations indexed

About

Lucile Broyer is a scholar working on Immunology, Biomaterials and Molecular Biology. According to data from OpenAlex, Lucile Broyer has authored 9 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 3 papers in Biomaterials and 2 papers in Molecular Biology. Recurrent topics in Lucile Broyer's work include Phagocytosis and Immune Regulation (7 papers), Immunotherapy and Immune Responses (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Lucile Broyer is often cited by papers focused on Phagocytosis and Immune Regulation (7 papers), Immunotherapy and Immune Responses (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Lucile Broyer collaborates with scholars based in Switzerland, France and United Kingdom. Lucile Broyer's co-authors include Matthieu Broussas, Liliane Goetsch, Krzysztof Masternak, Valéry Moine, Sébastien Calloud, Nicolas Fischer, Marie Kosco‐Vilbois, Elie Dheilly, Robert Nelson and Laura Cons and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Therapy.

In The Last Decade

Lucile Broyer

9 papers receiving 215 citations

Peers

Lucile Broyer

IMMUN

ONCOL

RNMI

MB

PHYSI

Valéry Moine Switzerland

Siham Farhane France

Emine Gulsen Gunes United States

Yueyao Yang China

Ellen Brenner Germany

Loïc Steiner Sweden

Fumito Tamura Japan

Jitesh Chauhan United Kingdom

Qianwen Zeng China

Oliver Kanaan Germany

Valéry Moine Switzerland

Lucile Broyer

149 ×1.1

IMMUN

81 ×1.0

ONCOL

59 ×1.0

RNMI

52 ×1.0

MB

30 ×1.0

PHYSI

Citations per year, relative to Lucile Broyer Lucile Broyer (= 1×) peers Valéry Moine

Countries citing papers authored by Lucile Broyer

Since Specialization

Citations

This map shows the geographic impact of Lucile Broyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucile Broyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucile Broyer more than expected).

Fields of papers citing papers by Lucile Broyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucile Broyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucile Broyer. The network helps show where Lucile Broyer may publish in the future.

Co-authorship network of co-authors of Lucile Broyer

This figure shows the co-authorship network connecting the top 25 collaborators of Lucile Broyer. A scholar is included among the top collaborators of Lucile Broyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucile Broyer. Lucile Broyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hatterer, Eric, Xavier Chauchet, Françoise Richard, et al.. (2020). Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors. mAbs. 12(1). 1739408–1739408. 33 indexed citations

2.

Moine, Valéry, Xavier Chauchet, Lucile Broyer, et al.. (2019). Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth. Cancer Immunology Research. 7(2_Supplement). A088–A088. 1 indexed citations

3.

Moine, Valéry, Lucile Broyer, Xavier Chauchet, et al.. (2018). Abstract 2770: Dual-targeting mesothelin/CD47 bispecific antibodies for tumor-directed blockade of CD47 in solid cancer. Cancer Research. 78(13_Supplement). 2770–2770. 1 indexed citations

4.

Dheilly, Elie, Valéry Moine, Gérard Didelot, et al.. (2018). Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity. Antibodies. 7(1). 3–3. 19 indexed citations

5.

Dheilly, Elie, Valéry Moine, Lucile Broyer, et al.. (2017). Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies. Molecular Therapy. 25(2). 523–533. 116 indexed citations

6.

Masternak, Krzysztof, Zoë Johnson, Vanessa Buatois, et al.. (2015). Abstract B54: Antagonizing CD47-SIRP alpha interaction with a bispecific antibody: A novel cancer immunotherapy approach. Cancer Immunology Research. 3(10_Supplement). B54–B54. 1 indexed citations

7.

Johnson, Zoë, Anne Papaioannou, Lucie Bernard, et al.. (2015). Bispecific antibody targeting of CD47/CD19 to promote enhanced phagocytosis of patient B lymphoma cells.. Journal of Clinical Oncology. 33(15_suppl). e14016–e14016. 7 indexed citations

8.

Broyer, Lucile, Liliane Goetsch, & Matthieu Broussas. (2013). Evaluation of Complement-Dependent Cytotoxicity Using ATP Measurement and C1q/C4b Binding. Methods in molecular biology. 988. 319–329. 9 indexed citations

9.

Broussas, Matthieu, Lucile Broyer, & Liliane Goetsch. (2013). Evaluation of Antibody-Dependent Cell Cytotoxicity Using Lactate Dehydrogenase (LDH) Measurement. Methods in molecular biology. 988. 305–317. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact